πŸ‡ΊπŸ‡Έ FDA
Patent

US 8637077

Sustained-release preparation

granted A61KA61K38/27A61K47/18

Quick answer

US patent 8637077 (Sustained-release preparation) held by Takeda Pharmaceutical Company Limited expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/27, A61K47/18, A61K47/183, A61K47/186